id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-304285-mfztp5om	McNabb-Baltar, Julia	Lipase Elevation in Patients With COVID-19	2020-06-03		.txt	text/plain	1229	83	47	DISCUSSION: Although a mild elevation in serum lipase was observed in some patients with COVID-19, clinical acute pancreatitis was not seen. A recent report from China described evidence of pancreatic injury, defined as elevated lipase, in up to 17% of active COVID-19 cases (2) . The second patient (a 61-year-old woman with Crohn's disease and serum lipase 275 U/L) reported nausea, vomiting, mild general abdominal pain, diarrhea, and anorexia. Previous reports have described the association between COVID-19 and gastrointestinal manifestations, such as liver injury, abdominal pain, diarrhea, nausea, and vomiting. A recent report from China revealed that up to 17% of patients with COVID-19 presented with some form of pancreatic injury, which was associated with a more severe initial presentation, but not worse outcomes (2) . We recently reported that 48% of patients presenting with elevated lipase exceeding 3 times the upper limit of normal were because of nonpancreatic etiologies, including gastritis/gastroparesis in 12% and enteritis/colitis in 18% (5).	./cache/cord-304285-mfztp5om.txt	./txt/cord-304285-mfztp5om.txt